Alpa Laboratories Limited Share Price & Analysis
₹67.64▼ -1.33%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹67.64
-1.33%
Open
₹—
High
₹69.45
Low
₹67.5
Close
₹67.64
52W High
₹106
52W Low
₹46
Volume
7K
Lot Size
1
Sector
Healthcare
Market Cap
₹144 Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
9.6
Sector P/E
54.4
P/B
0.76
EPS
₹5.53
ROE
8.39%
ROCE
9.42%
D/E Ratio
0.02
Div Yield
0%
Book Value
₹88.5
+
Strengths
- ✓Attractively valued vs sector (P/E 9.6x vs industry 54.4x)
- ✓Trading below book value (P/B 0.8x)
- ✓Virtually debt-free
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ALPA · as of Mar 2026
Promoters57.29%
FII0.40%▲0.05
Public42.30%▼0.04
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% |
| FII | 0.95% | 0.50% | 0.36% | 0.74% | 0.35% | 0.40% |
| Public | 41.74% | 42.21% | 42.35% | 41.97% | 42.34% | 42.30% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026
Results28 May 2026
Annual General Meeting
AGM19 Sept 2024
Annual General Meeting
AGM20 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹29.05 Cr ▲10.6% | ₹26.26 Cr ▲37.4% | ₹19.11 Cr ▼52.1% | ₹39.92 Cr ▲52.7% | ₹26.15 Cr ▲4.9% | ₹24.94 Cr ▲16.3% | ₹21.44 Cr ▼9.2% | ₹23.61 Cr |
| Op. Profit | ₹1.51 Cr ▲167.1% | ₹-2.25 Cr ▼623.3% | ₹0.43 Cr ▲115.0% | ₹0.2 Cr ▼73.0% | ₹0.74 Cr ▼77.7% | ₹3.32 Cr ▲526.4% | ₹0.53 Cr ▼84.9% | ₹3.51 Cr |
| OPM | 5.2% ▲160.7% | -8.6% ▼480.9% | 2.3% ▲350.0% | 0.5% ▼82.3% | 2.8% ▼78.7% | 13.3% ▲438.9% | 2.5% ▼83.4% | 14.9% |
| Net Profit | ₹1.59 Cr ▲1345.5% | ₹0.11 Cr ▼99.1% | ₹11.77 Cr ▲655.2% | ₹-2.12 Cr ▼123.8% | ₹8.9 Cr ▲15.7% | ₹7.69 Cr ▲50.8% | ₹5.1 Cr ▲43.7% | ₹3.55 Cr |
| EPS (₹) | 0.76 ▲1420.0% | 0.05 ▼99.1% | 5.59 ▲653.5% | -1.01 ▼123.9% | 4.23 ▲15.9% | 3.65 ▲50.8% | 2.42 ▲43.2% | 1.69 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹106 Cr ▼3.6% | ₹110 Cr ▲0.9% | ₹109 Cr ▲17.2% | ₹93 Cr ▼17.0% | ₹112 Cr ▲15.5% | ₹97 Cr ▲14.1% | ₹85 Cr ▲10.4% | ₹77 Cr ▲24.2% | ₹62 Cr ▼1.6% | ₹63 Cr |
| Expenses | ₹103 Cr ▼1.9% | ₹105 Cr ▲5.0% | ₹100 Cr ▲17.6% | ₹85 Cr ▼15.8% | ₹101 Cr ▲12.2% | ₹90 Cr ▲12.5% | ₹80 Cr ▲5.3% | ₹76 Cr ▲31.0% | ₹58 Cr ▲3.6% | ₹56 Cr |
| Op. Profit | ₹3 Cr ▼40.0% | ₹5 Cr ▼44.4% | ₹9 Cr ▲12.5% | ₹8 Cr ▼27.3% | ₹11 Cr ▲37.5% | ₹8 Cr ▲33.3% | ₹6 Cr ▲500.0% | ₹1 Cr ▼75.0% | ₹4 Cr ▼42.9% | ₹7 Cr |
| OPM | 3.0% ▼25.0% | 4.0% ▼50.0% | 8.0% ▼11.1% | 9.0% ▼10.0% | 10.0% ▲25.0% | 8.0% ▲14.3% | 7.0% ▲600.0% | 1.0% ▼85.7% | 7.0% ▼36.4% | 11.0% |
| Other Income | ₹16 Cr ▼30.4% | ₹23 Cr ▲64.3% | ₹14 Cr ▲55.6% | ₹9 Cr ▼18.2% | ₹11 Cr ▲175.0% | ₹4 Cr | ₹0 Cr ▼100.0% | ₹5 Cr ▲0.0% | ₹5 Cr ▲66.7% | ₹3 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼50.0% | ₹2 Cr |
| Depreciation | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼66.7% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr |
| PBT | ₹17 Cr ▼34.6% | ₹26 Cr ▲23.8% | ₹21 Cr ▲31.3% | ₹16 Cr ▼20.0% | ₹20 Cr ▲81.8% | ₹11 Cr ▲266.7% | ₹3 Cr ▲0.0% | ₹3 Cr ▼40.0% | ₹5 Cr ▼16.7% | ₹6 Cr |
| Tax % | 10.0% ▼58.3% | 24.0% ▲26.3% | 19.0% ▼9.5% | 21.0% ▼25.0% | 28.0% ▼15.2% | 33.0% ▼8.3% | 36.0% ▼42.9% | 63.0% ▲61.5% | 39.0% ▼29.1% | 55.0% |
| Net Profit | ₹15 Cr ▼25.0% | ₹20 Cr ▲17.6% | ₹17 Cr ▲30.8% | ₹13 Cr ▼7.1% | ₹14 Cr ▲100.0% | ₹7 Cr ▲250.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼66.7% | ₹3 Cr ▲0.0% | ₹3 Cr |
| EPS (₹) | 7.13 ▼23.1% | 9.27 ▲16.2% | 7.98 ▲33.4% | 5.98 ▼10.7% | 6.7 ▲94.2% | 3.45 ▲292.0% | 0.88 ▲83.3% | 0.48 ▼64.2% | 1.34 ▲11.7% | 1.2 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr |
| Reserves | ₹162 Cr ▲8.0% | ₹150 Cr ▲14.5% | ₹131 Cr ▲14.9% | ₹114 Cr ▲12.9% | ₹101 Cr ▲16.1% | ₹87 Cr ▲10.1% | ₹79 Cr ▲2.6% | ₹77 Cr ▲0.0% | ₹77 Cr ▲4.1% | ₹74 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr ▼100.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▼66.7% | ₹6 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr ▼66.7% | ₹6 Cr ▼45.5% | ₹11 Cr |
| Other Liabilities | ₹54 Cr ▲5.9% | ₹51 Cr ▲104.0% | ₹25 Cr ▼16.7% | ₹30 Cr ▲7.1% | ₹28 Cr ▼15.2% | ₹33 Cr ▲57.1% | ₹21 Cr ▲0.0% | ₹21 Cr ▲16.7% | ₹18 Cr ▼10.0% | ₹20 Cr |
| Total Liabilities | ₹238 Cr ▲6.7% | ₹223 Cr ▲22.5% | ₹182 Cr ▲9.0% | ₹167 Cr ▲7.7% | ₹155 Cr ▲10.7% | ₹140 Cr ▲15.7% | ₹121 Cr ▲0.0% | ₹121 Cr ▼0.8% | ₹122 Cr ▼3.2% | ₹126 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹21 Cr ▲0.0% | ₹21 Cr ▲90.9% | ₹11 Cr ▲57.1% | ₹7 Cr ▼22.2% | ₹9 Cr ▲28.6% | ₹7 Cr ▲16.7% | ₹6 Cr ▼25.0% | ₹8 Cr ▼20.0% | ₹10 Cr ▼33.3% | ₹15 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr ▲100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹145 Cr ▲22.9% | ₹118 Cr ▲20.4% | ₹98 Cr ▲25.6% | ₹78 Cr ▲4.0% | ₹75 Cr ▲47.1% | ₹51 Cr ▼10.5% | ₹57 Cr ▲16.3% | ₹49 Cr ▲58.1% | ₹31 Cr ▲138.5% | ₹13 Cr |
| Other Assets | ₹71 Cr ▼15.5% | ₹84 Cr ▲15.1% | ₹73 Cr ▼11.0% | ₹82 Cr ▲15.5% | ₹71 Cr ▼12.3% | ₹81 Cr ▲39.7% | ₹58 Cr ▼10.8% | ₹65 Cr ▼19.8% | ₹81 Cr ▼16.5% | ₹97 Cr |
| Total Assets | ₹238 Cr ▲6.7% | ₹223 Cr ▲22.5% | ₹182 Cr ▲9.0% | ₹167 Cr ▲7.7% | ₹155 Cr ▲10.7% | ₹140 Cr ▲15.7% | ₹121 Cr ▲0.0% | ₹121 Cr ▼0.8% | ₹122 Cr ▼3.2% | ₹126 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹18 Cr ▲350.0% | ₹4 Cr ▼55.6% | ₹9 Cr ▼10.0% | ₹10 Cr ▲600.0% | ₹-2 Cr ▼111.1% | ₹18 Cr ▲1900.0% | ₹-1 Cr ▲92.3% | ₹-13 Cr ▼176.5% | ₹17 Cr ▲177.3% | ₹-22 Cr |
| Investing CF | ₹-12 Cr ▲7.7% | ₹-13 Cr ▼750.0% | ₹2 Cr ▲112.5% | ₹-16 Cr ▼366.7% | ₹6 Cr ▲154.5% | ₹-11 Cr ▲26.7% | ₹-15 Cr ▼36.4% | ₹-11 Cr ▼450.0% | ₹-2 Cr ▲75.0% | ₹-8 Cr |
| Financing CF | ₹-5 Cr ▼266.7% | ₹3 Cr ▲175.0% | ₹-4 Cr ▼180.0% | ₹5 Cr | ₹0 Cr ▲100.0% | ₹-1 Cr ▲80.0% | ₹-5 Cr ▼155.6% | ₹9 Cr ▲160.0% | ₹-15 Cr ▼150.0% | ₹-6 Cr |
| Net Cash Flow | ₹1 Cr ▲114.3% | ₹-7 Cr ▼200.0% | ₹7 Cr | ₹0 Cr ▼100.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▲125.0% | ₹-20 Cr ▼33.3% | ₹-15 Cr | ₹0 Cr ▲100.0% | ₹-36 Cr |
| Free Cash Flow | ₹7 Cr ▲333.3% | ₹-3 Cr ▼137.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▲260.0% | ₹-5 Cr ▼133.3% | ₹15 Cr ▲850.0% | ₹-2 Cr ▲86.7% | ₹-15 Cr ▼193.8% | ₹16 Cr ▲150.0% | ₹-32 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 155d ▲12.3% | 138d ▼25.0% | 184d ▲48.4% | 124d ▼6.8% | 133d ▲26.7% | 105d ▼26.1% | 142d ▼7.2% | 153d ▼8.9% | 168d ▼28.2% | 234d |
| Inventory Days | 92d ▲26.0% | 73d ▼13.1% | 84d ▲3.7% | 81d ▼20.6% | 102d ▲13.3% | 90d ▼14.3% | 105d ▼23.9% | 138d ▲5.3% | 131d ▼33.2% | 196d |
| Days Payable | 97d ▲54.0% | 63d ▼37.0% | 100d ▲28.2% | 78d ▼48.7% | 152d ▲55.1% | 98d ▼1.0% | 99d ▼26.1% | 134d ▼4.3% | 140d ▼42.6% | 244d |
| Cash Conv. Cycle | 150d ▲0.7% | 149d ▼11.3% | 168d ▲32.3% | 127d ▲53.0% | 83d ▼14.4% | 97d ▼34.9% | 149d ▼5.1% | 157d ▼1.3% | 159d ▼15.0% | 187d |
| Working Capital Days | 110d ▼18.5% | 135d ▼11.2% | 152d ▲28.8% | 118d ▼15.7% | 140d ▲12.0% | 125d ▼35.6% | 194d ▼6.7% | 208d ▲19.5% | 174d ▼14.7% | 204d |
| ROCE | 16.0% ▲6.7% | 15.0% ▲25.0% | 12.0% ▲33.3% | 9.0% ▲28.6% | 7.0% ▲40.0% | 5.0% ▲66.7% | 3.0% ▼50.0% | 6.0% ▼25.0% | 8.0% ▼20.0% | 10.0% |
Source: Screener.in · Lower days = better efficiency
About Alpa Laboratories Limited
Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Alpa Laboratories Limited share price today?▾
Alpa Laboratories Limited (ALPA) is currently trading at ₹67.64 on NSE, down 1.33% as of the last market session. Prices update daily after market close on MarketNetra.
Is Alpa Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Alpa Laboratories Limited (ALPA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Alpa Laboratories Limited 52-week high and low?▾
Alpa Laboratories Limited's 52-week high is ₹106 and the 52-week low is ₹46. The current price of ₹67.64 is 36.2% below the 52W high.
What is Alpa Laboratories Limited P/E ratio?▾
Alpa Laboratories Limited's current P/E ratio is 9.6. This indicates the market is paying ₹9.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Alpa Laboratories Limited options?▾
Alpa Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ALPA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.